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METABOLITE PROFILING 
Chair:  Dave Millington 
Room:  Theater 
TOApm 03:00 Differences in Technology and Performance of 
Qualitative and Quantitative Metabolite Profiling 
Approaches; Armin Graber1; Klaus Weinberger1; 
Steven Ramsay1; Julie Wingate2; 1BIOCRATES Life 
Sciences , Innsbruck, Austria; 2Applied Biosystems, 
Concord, ON, Canada 
TOApm 03:20 Measuring Fifteen Endogenous Estrogens 
Simultaneously in Human Urine by High-
Performance Liquid Chromatography-Mass 
Spectrometry; Xia Xu1; Stephen D Fox1; John M 
Roman1; Haleem J Issaq1; Roni Falk2; Joseph E 
Saavedra3; Larry K Keefer3; Regina G Ziegler2; 
Timothy D Veenstra1; 1SAIC-Frederick, Inc., Frederick, 
MD; 2National Cancer Institute, Bethesda, MD; 
3National Cancer Institute at Frederick, Frederick, MD 
TOApm 03:40 Novel Approaches to Facilitate Structural 
Characterisation of Low-Level Circulating 
Metabolites; Angus N R Nedderman; Mark E Savage; 
Pfizer Global Research and Development, Sandwich, 
UK 
TOApm 04:00 Doping Control Analysis of Anti-Diabetic 
Therapeutics in Human Plasma and Urine; Mario 
Thevis1; Andreas Thomas1; Hans  Geyer1; Wilhelm 
Schänzer1; Philippe Delahaut2; Alain Bosseloir3; 
1Institute of Biochemistry, German Sport University, 
Cologne, Germany; 2Centre d’Economie Rurale, 
Marloie, Belgium; 3ZenTech, Angleur, Belgium 
TOApm 04:20 In Vivo Rat Metabolism of Intravenous Artesunate, 
a Drug for the Treatment of Severe and 
Complicated Malaria; Kirsten S. Smith; Young S. 
Yang; Lisa H. Xie; Charles A. DiTusa; Philip L. Smith; 
Qigui Li; Walter Reed Army Institute of Research, 
Silver Spring, MD 
TOApm 04:40 A Consistent, Versatile, Sensitive, and Cost Effective 
Methodology for Conducting Radiolabeled Studies 
in Drug Disposition; Todd Gillespie1; Edward 
Mattiuz1; Mike Lee2; Gary  alaskovic3; 1Eli Lilly and 
Company, Indianapolis, IN; 2Milestone Development, 
Newtown, PA; 3New Objective, Inc., Woburn, MA 
RNA AND DNA DRUG COMPLEXES 
Chair:  Valerie Gabelica 
Room:  214 
TOBpm 03:00 ESI MS/MS of Drug-DNA Non Covalent Complexes; 
Edwin A. De Pauw; Valerie Gabelica; Rosu Frederic; 
Chemistry, Liege, Belgium 
TOBpm 03:20 Evaluation of DNA Binding by Novel Intercalators 
using Electrospray Ionization Mass Spectrometry; 
Jennifer S. Brodbelt; Carolyn Mazzitelli; Sean  Kerwin; 
Brent  Iverson; Jeeyeon  Lee; University of Texas, 
Austin, TX 
TOBpm 03:40 The Investigation of Stacking and Binding 
Interactions of Cationic Porphyrins with G-
Quadruplexes using Ion Mobility Mass 
Spectrometry; Erin M. Baker1; Valérie Gabelica2; 
Summer L. Bernstein1; Nick Dupuis1; Jeong T. Lee3; 
Jonathan L. Sessler3; Michael T.  Bowers1; 1University 
of California, Santa Barbara, CA; 2University of Liège, 
Liège, Belgium; 3University of Texas, Austin, TX 
TOBpm 04:00 Mapping Non-Covalent Drug Binding to HIV-1 
&Psi;-RNA by Tandem Mass Spectrometry; Kevin 
B. Turner; Nathan A. Hagan; Daniele Fabris; University 
of Maryland Baltimore County, Baltimore, MD 
TOBpm 04:20 Investigating RNA-Transition Metal Complex 
Interactions: the Roles of Pseudouridine and GU 
Mismatches in Recognition; Jason W. Kieltyka1; 
Tetsuya Hasegawa2; Takashi Morii2; Christine S. 
Chow1; 1Wayne State University, Detroit, MI; 2Kyoto 
University, Uji, Kyoto, Japan 
TOBpm 04:40 Characterization of Nucleic Acid Higher Order 
Structure by Fourier Transform Ion Cyclotron 
Resonance Mass Spectrometry; Jingjie Mo; Kristina 
Håkansson; University of Michigan, Ann Arbor, MI 
HYDROPHOBIC PEPTIDES AND MEMBRANE PROTEINS 
Chair:  Dan Knapp 
Room:  217 
TOCpm 03:00 Analysis of Integral Membrane Protein Modification 
and Membrane Proteomes; Kevin L Schey; Medical 
University of South Carolina, Charleston, SC 
TOCpm 03:20 Quantitative Profiling of the Plasma Membrane 
Proteome of Hypoxic B16F10 Malignant Melanoma 
Cells using Stable Isotope Labeling; Josip Blonder1; 
Luke H Stockwin2; David A Lucas1; Thomas P 
Conrads1; King C Chan1; Maja A Bumke2; Dianne L 
Newton2; Haleem J Issaq1; Susanna M Rybak2; 
Timothy D Veenstra1; 1SAIC-Frederick, Inc., Frederick, 
MD; 2National Cancer Institute at Frederick, 
Frederick, MD 
TOCpm 03:40 2D-Chromatography For Top-Down Proteomics Of 
Integral Membrane Proteins; Julian P. Whitelegge1; 
Puneet Souda1; Kenneth Conklin1; Alek  Dooley1; Tom 
Vondriska5; Kym F. Faull1; 1The Pasarow Mass 
Spectrometry Laboratory, UCL , Los Angeles, CA; 
2Dept. of Psychiatry, UCLA, Los Angeles, CA; 
3Molecular Biology Institute, UCLA, Los Angeles, CA; 
4The Brain Research Institute, UCLA, Los Angeles, C ; 
5Cardiovascular Research Laboratories, UCLA, Los 
Angeles, CA   
TOCpm 04:00 Quantification of Membrane or Membrane-Bound 
Proteins Between Normal and Malignant Cells 
Isolated from the Same Patient with Primary Breast 
Cancer; Xiquan  Liang; Mahbod R. Hajivandi; 
Marshall Pope; Invitrogen, Carlsbad, CA 
TOCpm 04:20 A Novel Proteomic Approach for High Throughput 
Membrane Protein Analysis; Xiaoning Lu; Kei 
Fukada; Alexis Vien; Haining Zhu; University of 
Kentucky, Lexington, KY 
TOCpm 04:40 Solvent-Free MALDI-MS for the Analysis of 
Hydrophobic Peptides and Membrane Proteins via 
the Mini-Ball Mill Approach; Sarah Trimpin1; Peter 
S. Spencer2; Max. L.  Deinzer1; 1Oregon State 
University, Corvallis, OR; 2Center for Res. on Occupat. 
& Environ. Toxicol., Portland, OR 
INSTRUMENTATION: TOF MS 
Chair:  Douglas Barofsky 
Room:  Ballroom C1 
TODpm 03:00 New MALDI TOF-TOF Optics with Improved 
Performance; Jennifer M. Campbell1; Kevin M. 
Hayden2; Marvin L. Vestal3; 1Applied Biosystems, 
Framingham, MA; 2MDS Sciex, Framingham, MA; 
3Virgin Instruments, Framingham, MA 
TODpm 03:20 TOF Mass Spectrometer with ESI Source, 
Orthogonal Injection, and 16 kV Acceleration 
Voltage, for Study of Noncovalent Complexes; 
Viacheslav I Kozlovski2; Lynda J Donald1; Vladimir 
Montero-Collada1; Alexandre V Loboda3; Igor V 
Chernushevich3; Werner Ens1; Kenneth G Standing1; 
1University of Manitoba, Winnipeg, MB Canada; 
2Institute of Energy Problems of Chemical Physics, 
Chernogolovka, Russia; 3Sciex , Concord, ON Canada 
